Adult respiratory distress syndrome in patients with severe neutropenia.
暂无分享,去创建一个
F. Ognibene | J. Shelhamer | J. Parrillo | M. Parker | S. E. Martin | C. Burch | T. Schlesinger | P. Roach
[1] D. Fearon,et al. Neutrophil activation in thermal injury as assessed by increased expression of complement receptors. , 1986, The New England journal of medicine.
[2] J. Shelhamer,et al. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. , 1985, The Journal of clinical investigation.
[3] J. Solomkin,et al. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man. , 1985, Surgery.
[4] P. Hasleton. Adult respiratory distress syndrome—a review , 1983, Histopathology.
[5] A. Goldberg,et al. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. , 1983, The New England journal of medicine.
[6] G. H. Clowes,et al. Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. , 1983, The New England journal of medicine.
[7] R. Spragg,et al. Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. , 1983, The Journal of clinical investigation.
[8] R. Rogers,et al. Adult respiratory-distress syndrome: changing concepts of lung injury and repair. , 1982, The New England journal of medicine.
[9] A. Fein,et al. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome. , 1981, The New England journal of medicine.
[10] J. Cooper,et al. Prostaglandin production associated with the pulmonary vascular response to complement activation. , 1980, Surgery.
[11] S. Hosea,et al. Role of complement activation in a model of adult respiratory distress syndrome. , 1980, The Journal of clinical investigation.
[12] D. Lanier,et al. Reduction by cimetidine of serum parathyroid hormone levels in uremic patients. , 1980, The New England journal of medicine.
[13] G. Larsen,et al. Complement fragments, alveolar macrophages, and alveolitis. , 1979, The American journal of pathology.
[14] H. Jacob,et al. Granulocyte aggregation as a manifestation of membrane interactions with complement: possible role in leukocyte margination, microvascular occlusion, and endothelial damage. , 1979, Seminars in hematology.
[15] J. Crapo,et al. Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. I. Light microscopy. , 1979, The American journal of pathology.
[16] J. White,et al. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. , 1977, The Journal of clinical investigation.
[17] R. Bone,et al. Intravascular coagulation associated with the adult respiratory distress syndrome. , 1976, The American journal of medicine.
[18] T. Saldeen. Trends in microvascular research. The microembolism syndrome. , 1976, Microvascular research.
[19] M. Whitcomb. Drug-induced lung disease. , 1973, Chest.
[20] N. Ratliff,et al. The lung in hemorrhagic shock. IV. The role of neutrophilic polymorphonuclear leukocytes. , 1971, The American journal of pathology.
[21] G Nash,et al. Pulmonary lesions associated with oxygen therapy and artificial ventilation. , 1967, Laval medical.